Tag Archives: Collaborative Research

Plans for Meeting the Dementia Challenge by 2020 (DHSC)

Posted on February 24, 2019 by Dementia and Elderly Care News

Summary The Prime Minister’s Challenge on Dementia 2020 (2015) involved over 50 commitments for making England the best place in the world for dementia care, research and public dementia awareness in general. Feedback was subsequently collected, during 2018, concerning developments … Continue reading →

Research Towards a World Without Dementia: Marking World Alzheimer’s Day / World Alzheimer’s Month 2017 (Alzheimer’s Disease International / Department of Health)

Posted on September 23, 2017 by Dementia and Elderly Care News

Summary Information is available from Alzheimer’s Disease International (ADI) concerning World Alzheimer’s Month (September) and World Alzheimer’s Day 2017, which was on September 21st 2017. The theme for this year’s World Alzheimer’s Month campaign is again “Remember Me”. The UK … Continue reading →

Posted in Charitable Bodies, Commissioning, Department of Health, Diagnosis, In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged 70th World Health Assembly Adopted Global Action Plan on Dementia, Ageing Population, Awareness, Awareness Campaigns, Awareness Raising, Carey Mulligan, Carey Mulligan: UK Global Dementia Friends Ambassador, Collaborative Research, Collaborative Working, Community and Voluntary Sector, Dementia Awareness Campaigns, Dementia Awareness Raising, Dementia Friends, Dementia Friends Programme, Dementia Research, Dementia Research Institute (DRI), Dementia-Friendly Communities, Dementia-Friendly Environments, Dementia-Friendly Organisations, Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, First G8 Dementia Summit, Former Health Secretary Jeremy Hunt, G8 Dementia Summit, G8 Dementia Summit Declaration, G8 Dementia Summit: Global Action Against Dementia, Global Action Against Dementia, Global Action Plan on Dementia, Global Alzheimer’s and Dementia Action Alliance, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Context, Global Dementia Friends Ambassadors, Global Leadership, International Collaborations, International Dementia Research, Leadership for Compassionate Care, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Partnership Working, Reducing Stigma, Research and Development, Research and Innovation, Research Commitment, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Stigma of Dementia, Stigma-Free Environments, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), Voluntary Organisations, WHO Global Action Plan on the Public Health Response to Dementia 2017-2025, World Alzheimer's Month 2017 (Remember Me), World Alzheimer’s Day 2017, World Alzheimer’s Month 2017, Yuichiro Miura: Japan’s Dementia Supporters Ambassador | Leave a comment

Collaborative Working Between CCGs and AHSNs: Strategic Commissioning (NHSCC / AHSNs)

Posted on June 1, 2017 by Dementia and Elderly Care News

Summary A briefing from NHS Clinical Commissioners (NHSCC) and Academic Health Science Networks (AHSNs) supplies case studies illustrating the potential benefits of collaborative working between CCGs and AHSNs. A clear focus on specific issues is recommended. Full Text Link Reference … Continue reading →

Posted in Charitable Bodies, Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, National, NHS, Non-Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Academic Health Science Network (AHSN) for South London, Academic Health Science Network for the North East and North Cumbria (AHSN NENC), Academic Health Science Networks (AHSNs), AHSN Network, Building Research Partnerships, Care Partnerships, CCGs: Clinical Commissioning Groups, Clinical Commissioning Groups (CCGs), Collaboration, Collaboration for Coordinated Care, Collaborative Commissioning, Collaborative Projects, Collaborative Research, Collaborative Working, Collaborative Working in Local Communities, Collaborative Working in Local Communities for Benefit of Patients, DOACs, East Lancashire CCG, East Midlands AHSN, East Midlands CCGs, Health Innovation Network (South London AHSN), Healthier You: NHS Diabetes Prevention Programme, Imperial College Health Partners, Kent CCGs, Kent Surrey and Sussex AHSN, Kent Surrey Sussex AHSN, Local AHSNs, Local Strategic Commissioning, London Borough of Newham, London CCGs, Low Cost Care Coordination, Neurorehabilitation Pathways, Newham CCG, NHS Clinical Commissioners, NHS Clinical Commissioners (NHSCC), NHS Diabetes Prevention Programme, NHS Diabetes Prevention Programme (NHS DPP), NHS England AHSN Network, NHS Newcastle Gateshead CCG, NHSCC: NHS Clinical Commissioners, North East and North Cumbria AHSN, North West Coast Innovation Agency, North West Coastal AHSN, North West London CCGs, Nottingham Biomedical Research Centre, Partnership Working, Population Health Improvement, Reducing A&E Admissions, Reducing Strokes Due to Atrial Fibrillation, Research Into Practice, Scarred Liver Project, Somerset CCG, South West AHSN, Strategic Commissioning, Sustainability and Transformation Partnerships, System-Wide Learning and Collaboration, UCLPartners, Unplanned Hospital Admissions, Wessex AHSN | Leave a comment

New Drugs for Dementia (POST Note PN 535)

Posted on August 29, 2016 by Dementia and Elderly Care News

Summary The Parliamentary Office of Science and Technology (POST) has produced a briefing outlining some of the challenges in developing new drugs for dementia, explained in the context of ongoing UK and international research programmes. There is an extensive bibliography, … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged Academic Institutes in the UK, Academy of Social Sciences, Aducanumab (Biogen), Alzheimer’s Association, Alzheimer’s Research UK’s Drug Discovery Alliance, Behavioural and Psychological Symptoms of Dementia (BPSD), Big Data, Big Data Funding and Research, Big Pharma, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society (BPS), Co-ordination and Data Analytics, Cognitive Health in Ageing Register for Investigations, Collaborative Projects, Collaborative Research, Dementia Consortium, Dementia Risk Prevention, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), DPUK: Dementias Platform UK, Drug Discovery Alliance, Drug Licensing Approval, Drugs for BPSD, Drugs for Cognitive Symptoms of Cognitive Decline and Dementia, EAMS: Early Access to Medicines Scheme, Early Access to Medicines Scheme, Effective Non-Drug Interventions, Etanercept, European Prevention of Alzheimer's Dementia Consortium (EPAD), European Prevention of Alzheimer’s Dementia Consortium, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Join Dementia Research, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, New Drugs for Dementia (POST Note PN 535), NIHR Clinical Research Network, Observations & Trials in Dementia Research, Parliament, Parliamentary Office of Science & Technology, Parliamentary Office of Science & Technology (POST), Participation in Research, Patient Access to New Drugs, Pharmaceutical Industry, Pioglitazone, POST: Parliamentary Office of Science & Technology, Pre-Symptomatic Diagnosis of Dementia, Preclinical Biomarkers and Dementia, Preclinical Indicators and Dementia, Prevention, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Solanezumab (Eli Lilly), Symptom-Modifying Drugs for Dementia, UK Dementia Research Institute, UK Parliament, UK Patient Recruitment Initiatives, Verubecestat (Merck), Well-Being and Health for People With Dementia (WHELD) Program | Leave a comment

Two Further Improvements: Dementia Services Seven Days a Week / Dementia Awareness for People Aged Over Forty (BBC News / Department of Health)

Posted on March 14, 2016 by Dementia and Elderly Care News

Summary Two further aspects of the latest implementation plans for the Prime Minister’s Challenge on Dementia 2020 were emphasised a week ago. Seven day NHS services are planned to benefit dementia patients, with more frequent patient assessments and better care … Continue reading →

Latest Challenge on Dementia 2020 Implementation Plan (BBC News / Department of Health)

Posted on March 7, 2016 by Dementia and Elderly Care News

Summary The Prime Minister’s Challenge on Dementia 2020 contained over 50 commitments towards making England the best place in the world for dementia care, research and societal dementia awareness by 2020. The Department of Health’s updated implementation plan specifies how … Continue reading →

Posted in Acute Hospitals, Alzheimer's Society, Alzheimer’s Research UK, BBC News, Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Personalisation, Quick Insights, Standards, UK, Universal Interest | Tagged Achieving Dementia Friendly Acute care, Ageing and Dementia, Ageing and Society, Ageing Policy in the UK, Ageing Population, Alistair Burns: NHS England’s National Clinical Director for Dementia, Alzheimer's Association, Alzheimer’s Research UK (ARUK), Alzheimer’s Society Connecting Communities Project, Awareness and Understanding, Awareness Campaigns, BBC Health News, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Better Care Fund, Black Asian and Minority Ethnic (BAME), Black Asian and Minority Ethnic Communities (UK), British Prime Minister's Office, Building Dementia Friendly Communities, Burden of Dementia, Care and Compassion, Care at Home, Carer Support, Carer Support Services, CCG Improvement and Assessment Framework (CCGIAF), Challenge on Dementia (David Cameron), Challenge on Dementia 2020, Challenge on Dementia 2020 Implementation Plan, Citizen Participation, Collaboration, Collaborative Projects, Collaborative Research, Collaborative Working, Commitment to Carers (NHS England), Community Participation, Compassionate Care, Connecting Communities, Connecting Communities Initiative, Creating Dementia Friendly Environments, Creating Dementia Friendly Hospitals, Cross-Sector Partnerships, David Cameron, DEEP2: Dementia Engagement and Empowerment Project, Dementia 2020 Citizens’ Panel, Dementia Action Alliance (DAA), Dementia Advisers, Dementia Advisor, Dementia Advisor Service, Dementia Awareness, Dementia Awareness Training, Dementia Challenge, Dementia Consortium, Dementia Friendly Charters, Dementia Friends, Dementia Friends Campaign, Dementia Friends Champions, Dementia Friends Programme, Dementia Health and Care Champion Group, Dementia Intelligence Network (DIN), Dementia Profile Tool, Dementia Programme Board, Dementia Research, Dementia Research Institute, Dementia Risk Factors, Dementia State of the Nation, Dementia UK, Dementia Voice, Dementia-Friendly Businesses, Dementia-Friendly Care Homes, Dementia-Friendly Cities, Dementia-Friendly Communities, Dementia-Friendly Employers, Dementia-Friendly Hospitals, Dementia-Friendly Housing, Dementia-Friendly Neighbourhoods, Dementia-Friendly Sectors, Dementia-Friendly Towns, Dementias Platform UK, Dementias Platform UK (DPUK), Department of Health Dementia Challenge, Department of Health Dementia Challenge (2020), Dignity in Care, Dignity in Dementia, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Elderly Human Rights, Global Action Against Dementia, Global Burden of Dementia, Global Clinical Trials Fund (GCTF), Global Fund on Dementia, Global Leadership, Global Outlook, Healthy Behaviours, Healthy Communities, Healthy Lifestyles, Improving Care for People with Dementia, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Integration of Health and Care, International Collaborations, International Dementia Research Inventories, International Programmes, Involvement and Participation, Jane Ellison, Join Dementia Research, Join Dementia Research: Recruitment Onto Dementia Studies, Joint Action on Dementia, Lifestyle Risk Factors, Local Dementia Action Alliances, Local Dementia Action Alliances in England, Local Government, Local Health and Care Economies, Local Health and Care Services, Local Health and Wellbeing Boards, Loneliness and Dementia, Loneliness and Social Isolation, Maintaining Independence, NHS England CCG Improvement and Assessment Framework, NHS England's Five Year Forward View (2014), NHS England’s Commitment to Carers, NHS Five Year Forward View (5YFV), NHS Health Check, NHS Health Check Programme, Organisation for Economic Co-operation and Development (OECD), Participation in Research, Participation in Research Studies, Partnership and Collaboration, Partnership Working, Patient and Public Participation, Prime Minister's Challenge on Dementia, Prime Minister's Office, Prime Minister’s Challenge On Dementia 2020, Prime Minister’s Dementia Challenge, Professor Alistair Burns, Public Health England (PHE), Public Health England Dementia Intelligence Network, Public Participation in Research, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Stigma, Referrals, Research and Innovation, Risk Factors, Risk Factors for Alzheimer's Diseease, Risk Management, Shared Delivery Plan for Health and Social Care, Support for Carers, Sustainable Care, Sustainable Health and Care Services, Tackling Barriers to Innovation, Tide Network, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, World Dementia Council, World Dementia Envoy, World Health Organization (WHO) | Leave a comment

Funding Initiative (JPco-fuND) for International Dementia Research (MRC)

Posted on October 11, 2015 by Dementia and Elderly Care News

Summary The EU Joint Programme for Neurodegenerative Disease Research (JPND) has announced €35 million (£25.7 million) funding for research into neurodegenerative diseases. Nine of the 21 research projects involved will benefit UK research teams; these will receive MRC funds through … Continue reading →

Care Quality Commission and Age UK Collaboration Explores Patient Experience of Care (CQC)

Posted on October 10, 2015 by Dementia and Elderly Care News

Summary The Care Quality Commission has entered into a six-month partnership with Age UK in an effort to discover, and act upon, older people’s experiences of care. This work may also help to identify examples of best practice. Full Text … Continue reading →

Pain in Impaired Cognition: EU COST Programme (COST TD1005 Action)

Posted on April 3, 2015 by Dementia and Elderly Care News

Summary The European Cooperation in the Field of Scientific and Technical Research (COST) offers an inter-governmental framework which sponsors and promotes collaboration between researchers in Europe. One component of this work is the EU-COST initiative entitled “Pain in impaired cognition, … Continue reading →

Posted in Acute Hospitals, Community Care, End of Life Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Models of Dementia Care, Pain, Person-Centred Care, Quick Insights, Systematic Reviews, UK | Tagged Academic Centre for Dentistry Amsterdam (ACTA): University of Amsterdam, Assessment of Pain in Elderly Patients With Severe Dementia, Back Pain, Barriers: Poor Pain Management, BMC Neurology, British Medical Bulletin, Centre for Elderly and Nursing Home Medicine: University of Bergen, Chronic Pain, Clinical Interventions in Aging, Collaboration, Collaborative Communication, Collaborative Projects, Collaborative Research, Collaborative Working, COST Action TD1005: Pain Assessment in Patients with Impaired Cognition Especially Dementia, COST TD1005 Action Work Group 1: Psychometrics and Algesimetry (WG1), COST TD1005 Action Work Group 2: Nursing and Care (WG2), COST TD1005 Action Work Group 3: Clinical Evaluation and Epidemiology (WG 3), COST TD1005 Action Work Group 4: Experimental Evaluation (WG 4), COST TD1005 Action Work Group 5: Palliative Care (WG 5), Decoding Pain From Facial Display of Patients With Dementia, Dementia Care in Acute General Hospitals, Dementia Care in Acute Settings, Dementia Care in General Hospitals, Department of Global Public Health and Primary Care: University of Bergen, Department of Oral Function: University of Amsterdam, Department of Public Health and Primary Care Medicine: Leiden University Medical Center, Department of Public Health and Primary Care: Leiden University Medical Center, EU COST Program for COST Action TD1005, EU COST Programme (COST TD1005 Action) Work Group 1 (WG 1): Psychometrics and Algesimetry, EU COST Programme (COST TD1005 Action) Work Group 2 (WG 2): Nursing and Care, EU COST Programme (COST TD1005 Action) Work Group 3 (WG 3): Clinical Evaluation and Epidemiology, EU COST Programme (COST TD1005 Action) Work Group 4 (WG 4): Experimental Evaluation, EU COST Programme (COST TD1005 Action) Work Group 5 (WG 5): Palliative Care, European Cooperation in the Field of Scientific and Technical Research (COST), Germany, Gerodontology, Headache, International Collaborations, Joint and Back Pain, Kings College London, Leiden University Medical Center, London, MOBID Pain Scale, Mobilization-Observation-Behaviour-Intensity-Dementia (MOBID) Pain Scale, Netherlands, Non-Profit Collaborations, Norway, Norway Stavanger University Hospital, Otto-Friedrich University Bamberg, Pain Agitation and Behavioural Problems in People With Dementia in General Hospital Wards, Pain and Disruptive Behaviour, Pain Assessment in Impaired Cognition, Pain Assessment in Impaired Cognition (PAIC) Meta-Tool, Pain Assessment in Patients with Impaired Cognition Especially Dementia (COST Action TD1005), Pain Assessment Tools, Pain Control, Pain in Impaired Cognition: EU COST Programme (COST TD1005 Action), Pain Management, Pain Management in Older People with Dementia, Pain Medicine, Pain Prevalence, Pain-Indicative Behaviours, Physiological Psychology: Otto-Friedrich University Bamberg, Research Institute MOVE Amsterdam, Stavanger University Hospital, Toothache, Treatment of Pain to Reduce Behavioural Disturbances, Underlying Causes of BPSD, University of Amsterdam, University of Bamberg (Germany), University of Bergen, Untreated Pain, VU University Amsterdam, VU University Medical Center Amsterdam, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Prime Minister’s Challenge On Dementia 2020: £300m Government Funding Planned For Dementia Research (BBC News / Department of Health)

Posted on February 22, 2015 by Dementia and Elderly Care News

Summary In the wake of the three-year Prime Minister’s “Dementia Challenge” (2012), David Cameron has announced the follow-up Prime Minister’s Challenge On Dementia 2020. The plan is to further transform dementia research, dementia care and support. It is anticipated that … Continue reading →

Tag Archives: Collaborative Research

Research Towards a World Without Dementia: Marking World Alzheimer’s Day / World Alzheimer’s Month 2017 (Alzheimer’s Disease International / Department of Health)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites